NCT03664336View on ClinicalTrials.gov

Refractory Diffuse Large B-cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

January 31, 2018

Conditions
Diffuse Large B-cell Lymphoma
Trial Locations (1)

Unknown

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03664336 - Refractory Diffuse Large B-cell Lymphoma | Biotech Hunter | Biotech Hunter